Cathie Wood Castle Biosciences Inc Transaction History

Ark Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$16.0 - $45.99 $18.7 Million - $53.8 Million	-1,170,111 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$33.17 - $46.98 $1.43 Million - $2.02 Million	-43,096 Reduced 3.55%	1,170,111 $52.5 Million
Q4 2021 Jan 28, 2022	SELL	$39.06 - $67.58 $33 Million - $57.1 Million	-844,660 Reduced 41.05%	1,213,207 $52 Million
Q3 2021 Nov 12, 2021	SELL	$60.13 - $77.6 $28.1 Million - $36.3 Million	-467,746 Reduced 18.52%	2,057,867 $137 Million
Q2 2021 Aug 05, 2021	SELL	$50.07 - $76.78 $3.59 Million - $5.5 Million	-71,675 Reduced 2.76%	2,525,613 $185 Million

Q1 2021 May 13, 2021	BUY	$58.92 - $97.33 $31.2 Million - $51.5 Million	528,696 Added 25.56%	2,597,288 $178 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $70.7 Million - $118 Million	1,620,867 Added 362.02%	2,068,592 $139 Million
Q3 2020 Oct 30, 2020	SELL	$38.47 - $52.03 $1 Million - $1.36 Million	-26,045 Reduced 5.5%	447,725 $23 Million
Q2 2020 Aug 11, 2020	BUY	$27.28 - $43.01 $6.91 Million - $10.9 Million	253,318 Added 114.91%	473,770 $17.9 Million
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $333,229 - $512,982	14,438 Added 7.01%	220,452 $6.57 Million
Q4 2019 Jan 31, 2020	BUY	$15.74 - $35.04 $628,450 - $1.4 Million	39,927 Added 24.04%	206,014 $7.08 Million
Q3 2019 Nov 12, 2019	BUY	$18.09 - $27.92 $3 Million - $4.64 Million	166,087 New	166,087 $3.01 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.